# South Korea Celiac Disease Treatment Market > South Korea Celiac Disease Treatment Market Research Report By Treatment Type (Gluten Free Diet, Vitamin and Minerals Supplements, Medical Therapies) and By End User (Hospitals and Clinics, Research Centers, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 11.62% - **2024:** $ 7.63 Million - **2025:** $ 8.52 Million - **2035:** $ 25.58 Million - **Key Players:** AbbVie Inc (US), Gluten Free Holdings Inc (US), Alba Therapeutics Corporation (US), TheraBreath (US), Aimmune Therapeutics Inc (US), Celiac Disease Foundation (US), Biomedal S.L. (ES), Nestle S.A. (CH) **Report ID:** MRFR/HC/49598-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-celiac-disease-treatment-market-51355 --- ## Market Summary ## **South Korea Celiac Disease Treatment Market Overview** As per MRFR analysis, the South Korea Celiac Disease Treatment Market Size was estimated at 13.74 (USD Million) in 2023. The South Korea Celiac Disease Treatment Market Industry is expected to grow from 15.25(USD Million) in 2024 to 49.55 (USD Million) by 2035. The South Korea Celiac Disease Treatment Market CAGR (growth rate) is expected to be around 11.307% during the forecast period (2025 - 2035) **Key South Korea Celiac Disease Treatment Market Trends Highlighted** In South Korea, the Celiac Disease Treatment Market is experiencing several significant trends driven by the growing awareness of gluten-related disorders and the rise in diagnoses of celiac disease. Increasing prevalence of the disease, as reported by local medical institutions and health organizations, is pushing the demand for effective treatment options and gluten-free products. This awareness is further enhanced by education campaigns from both governmental health entities and patient advocacy groups that emphasize the importance of strict adherence to a gluten-free lifestyle.  The trend towards functional foods and dietary supplements is also gaining momentum as consumers seek options that cater to their dietary restrictions while addressing their nutritional needs.The government of South Korea has actively supported dietary research as well as the development of gluten-free alternatives. This helps domestic producers increase their innovations and diversify their product lines. Furthermore, partnerships within the food industry and the healthcare sector promise new opportunities for specialized product development for celiac disease sufferers.  Recently, there has been growing interest in online and e-commerce platforms for the distribution of gluten-free products, making them more accessible to consumers throughout South Korea. Additionally, this phenomenon, along with the opening of specialized health food stores and supermarkets with gluten-free sections, indicates a deeper transformation towards a proactive dietary and health management culture. Furthermore, increased insurance coverage for celiac disease diagnosis and treatment is anticipated to play a crucial role in expanding the accessibility of treatment options in the region, thereby driving the market growth. Overall, the South Korean Celiac Disease Treatment Market is navigating a blend of heightened awareness, increased product availability, and supportive health policies, which collectively open new avenues for innovation and access in the treatment landscape. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** **South Korea Celiac Disease Treatment Market Drivers** **Increasing Awareness and Diagnosis of Celiac Disease** In South Korea, the awareness regarding celiac disease has significantly improved over the past few years, leading to better diagnosis and treatment options within the South Korea Celiac Disease Treatment Market Industry. The Korean Ministry of Health and Welfare has reported that the diagnosis rate of celiac disease has increased by over 30% in the last decade due to educational campaigns and improved testing methods.  This trend has encouraged more individuals to seek medical help and has created a demand for specialized treatment protocols.Furthermore, non-profit organizations such as the Korean Celiac Disease Society play a vital role in patient education, supporting initiatives aimed at raising awareness about the disease and advocating for gluten-free food availability. This increase in diagnosis is essential in generating a wider patient base, ultimately driving market growth as more treatments and healthcare services are required to cater to these newly diagnosed individuals. **Expansion of Gluten-Free Product Offerings** There has been a marked increase in the availability and variety of gluten-free products in South Korea, which is positively impacting the South Korea Celiac Disease Treatment Market Industry. Reports from the Korea Agro-Fisheries & Food Trade Corporation indicate that the gluten-free food segment has grown by approximately 40% over the past five years. Major food manufacturers and retailers are recognizing the growing market potential and are diversifying their product lines to include gluten-free options. Companies like Lotte and CJ CheilJedang have launched dedicated gluten-free products, allowing individuals with celiac disease to manage their dietary restrictions more effectively. This expansion benefits the healthcare system and the market by increasing accessibility to essential foods needed for patients and raising awareness about the disease. **Government Support and Regulatory Framework** The South Korean government has been increasingly proactive in establishing policies to support individuals with celiac disease, positively impacting the South Korea Celiac Disease Treatment Market Industry. Recent legislative movements have included efforts to improve labeling regulations on gluten-containing ingredients in food products. The Korean Food and Drug Administration has collaborated with health organizations to develop clearer regulations, ensuring that people with celiac disease have access to safe food options. According to a report from the Ministry of Food and Drug Safety, about 75% of consumers expressed a need for clearer labeling on gluten-free products. Such government interventions are fostering an environment that encourages product development, innovation, and enhances market growth by ensuring compliance and safety for patients. **South Korea Celiac Disease Treatment Market Segment Insights** **Celiac Disease Treatment Market Treatment Type Insights** In the South Korea Celiac Disease Treatment Market, the Treatment Type segment plays a pivotal role in shaping the therapeutic landscape for individuals suffering from this condition. The market is primarily driven by the necessity for effective management strategies that cater to the unique dietary and health needs of patients with celiac disease. One of the key approaches is the Gluten Free Diet, which forms the cornerstone of treatment for celiac disease. Adhering to a strict gluten-free diet not only alleviates symptoms but also plays a significant role in promoting the overall health and well-being of patients.  The rising awareness regarding the adverse effects of gluten among South Koreans has catalyzed a growing demand for gluten-free food products in supermarkets and restaurants, indicating a cultural shift towards healthier dietary choices.Additionally, Vitamin and Minerals Supplements are also an important aspect of treatment, considering that individuals with celiac disease often experience nutrient malabsorption. As the population gains a deeper understanding of how celiac disease can lead to nutritional deficiencies, the demand for these supplements continues to rise, indicating an opportunity for product development in this segment.  Medical therapies are emerging as an innovative avenue for treatment, with ongoing Research and Development efforts aimed at finding alternative solutions beyond traditional dietary management. Such therapies could offer promise for those who struggle with food restrictions or who have not achieved satisfactory health improvements through diet alone. As the South Korea Celiac Disease Treatment Market evolves, there will be increased investments in these treatment options, underscoring the need for multifaceted approaches to effectively manage this condition.Furthermore, the South Korean government has indicated interest in supporting health initiatives aimed at addressing chronic diseases, including celiac disease.  This policy landscape may foster collaborations between healthcare providers, governmental bodies, and food manufacturers, resulting in improved access to gluten-free products and nutritional supplements. Market participants will need to navigate challenges such as regulatory compliance and consumer education concerning dietary needs in celiac disease management. Overall, the Treatment Type segment is vital for the South Korea Celiac Disease Treatment Market, as it encapsulates the diverse pathways through which patients can achieve better health outcomes, influenced considerably by cultural, nutritional, and medical factors. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** **Celiac Disease Treatment Market End User Insights** The South Korea Celiac Disease Treatment Market is segmented based on End User, revealing a diverse landscape that plays a crucial role in addressing this health condition. Hospitals and Clinics form a significant portion of this market segment, providing essential diagnostic and therapeutic services for patients suffering from celiac disease. These facilities are equipped with specialized teams capable of delivering tailored treatments, which is vital for effective management of the disorder. Research Centers are also noteworthy players in this market, as they contribute to the advancement of innovative therapies and understandings of celiac disease. They often undertake critical studies that help in formulating new treatment guidelines and improving patient outcomes. Additionally, the Others category includes community health organizations and patient advocacy groups that support awareness and education, further enhancing overall treatment and management. The combined efforts of these end users reflect a robust approach to tackling celiac disease in South Korea, driven by increasing prevalence and awareness of gluten sensitivity among the population. This comprehensive network underscores the importance of collaboration across various sectors to improve the quality of life for affected individuals and optimize treatment pathways. **South Korea Celiac Disease Treatment Market Key Players and Competitive Insights** The competitive landscape of the South Korea Celiac Disease Treatment Market is characterized by a variety of key players, each contributing to the advancement of treatment options and solutions for managing celiac disease. This market is increasingly driven by a growing awareness of celiac disease among healthcare providers and patients alike, leading to an enhanced focus on innovative treatments and dietary solutions that meet the specific needs of those affected.  As consumers become more informed about the implications of celiac disease and the importance of adherence to a gluten-free lifestyle, companies in this market are compelled to innovate and effectively communicate the benefits of their products. The competition is intensified by rapid advancements in research and development, regulatory approvals, and the integration of cutting-edge technologies in treatment methodologies.Yuhan Corporation holds a notable position in the South Korea Celiac Disease Treatment Market due to its strong commitment to research and development. The company is renowned for its extensive experience in the pharmaceutical sector, which facilitates the creation of specialized products that cater to patients with celiac disease.  With a robust portfolio that emphasizes both innovative therapies and educational initiatives for gluten-free diets, Yuhan Corporation effectively engages healthcare professionals and patients. Its established distribution networks across South Korea enable the company to maintain a prominent presence within the market, ensuring timely access to essential treatments. The emphasis on quality and efficacy, coupled with strategic partnerships and collaborations within the healthcare ecosystem, further enhances Yuhan Corporation's standing in this competitive environment.Korean Medicine Co. is another significant player in the South Korea Celiac Disease Treatment Market, known for its dedication to traditional and modern therapeutic solutions tailored for individuals affected by celiac disease.  The company offers a range of products, including herbal formulations and gluten-free nutritional supplements, aimed at supporting patients in managing their symptoms and overall health. Korean Medicine Co. is recognized for its strong market presence, bolstered by effective marketing strategies and consumer education programs focused on the importance of gluten-free living. The company has made strides in merger and acquisition activities to expand its product offerings and foster innovation within its operations. Through these endeavors, Korean Medicine Co. solidifies its commitment to enhancing the quality of life for individuals with celiac disease while contributing to the overall growth and development of the treatment landscape in South Korea. **Key Companies in the South Korea Celiac Disease Treatment Market Include** **South Korea Celiac Disease Treatment Market Industry Developments** In recent months, the South Korea Celiac Disease Treatment Market has seen significant developments, particularly with a focus on innovative therapeutics and enhanced patient support services. There has been increased collaboration among major companies like Yuhan Corporation, JW Pharmaceutical, and Hanmi Pharmaceutical to develop advanced treatments and diagnostic tools for celiac disease. In September 2023, Yuhan Corporation announced successful outcomes from its clinical trials for a promising therapeutic candidate aimed at celiac disease, strengthening its market position.  Furthermore, in July 2023, JW Pharmaceutical and Boryung Pharmaceutical expanded their Research and Development collaborations to address unmet needs in celiac disease treatment.The market has also witnessed a growing public awareness campaign led by DongA ST, aiming to educate patients about gluten-free diets and ongoing treatment options. The Celiac Disease Treatment Market in South Korea is projected to experience notable growth, driven by the increasing incidence of the disease and a rise in healthcare spending. In addition, the government is fostering initiatives to promote policy adjustments benefiting those with celiac disease, enhancing the overall support infrastructure in the country. **South Korea Celiac Disease Treatment Market Segmentation Insights** ## Market Drivers ### Supportive Regulatory Framework A supportive regulatory framework is essential for the growth of the celiac disease-treatment market. In South Korea, government initiatives aimed at promoting health and wellness have led to increased funding for research and development in the field of celiac disease. Regulatory bodies are also working to ensure that gluten-free labeling is standardized, which helps consumers make informed choices. This supportive environment encourages manufacturers to invest in the development of new treatments and gluten-free products. As regulations evolve to better support patients with celiac disease, the market is likely to see an influx of innovative solutions, further driving its expansion. ### Rising Prevalence of Celiac Disease The increasing prevalence of celiac disease in South Korea is a crucial driver for the celiac disease-treatment market. Recent studies indicate that the incidence of celiac disease has risen, with estimates suggesting that approximately 1 in 100 individuals may be affected. This growing number of diagnosed cases necessitates a corresponding increase in treatment options and healthcare resources. As awareness of the disease expands, more individuals seek medical advice, leading to higher demand for gluten-free products and specialized treatments. The celiac disease-treatment market is thus likely to experience significant growth as healthcare providers and patients alike respond to this rising prevalence, creating opportunities for innovative therapies and dietary solutions. ### Advancements in Diagnostic Technologies Advancements in diagnostic technologies play a pivotal role in shaping the celiac disease-treatment market. Enhanced testing methods, such as genetic testing and serological assays, have improved the accuracy and speed of celiac disease diagnosis. These innovations enable healthcare professionals to identify affected individuals more efficiently, leading to earlier intervention and management of the disease. As diagnostic capabilities improve, the number of diagnosed cases is expected to rise, further driving the demand for effective treatment options. The celiac disease-treatment market is likely to benefit from these technological advancements, as they facilitate better patient outcomes and foster a more informed patient population. ### Growing Health Consciousness Among Consumers Growing health consciousness among consumers is a notable driver of the celiac disease-treatment market. In South Korea, there is an increasing trend towards healthier eating habits, with many individuals seeking to avoid gluten for perceived health benefits, even among those without celiac disease. This shift in consumer behavior has led to a surge in demand for gluten-free products and treatments. Market analysts suggest that this trend could potentially increase the overall market size, as more consumers opt for gluten-free diets. The celiac disease-treatment market stands to benefit from this heightened awareness, as it aligns with broader health trends and encourages the development of diverse treatment options. ### Increased Availability of Gluten-Free Products The increased availability of gluten-free products is a significant driver for the celiac disease-treatment market. In South Korea, the food industry has responded to the growing demand for gluten-free options, resulting in a wider range of products being offered in supermarkets and restaurants. This trend is supported by consumer awareness and the rising number of individuals diagnosed with celiac disease. Market data suggests that the gluten-free food segment is projected to grow at a CAGR of around 8% over the next few years. As more gluten-free products become accessible, patients are likely to adhere more closely to dietary restrictions, thereby enhancing their quality of life and driving further growth in the celiac disease-treatment market. ## Future Outlook The [Celiac Disease Treatment Market](https://www.marketresearchfuture.com/reports/celiac-disease-treatment-market-8474) is projected to grow at 11.62% CAGR from 2025 to 2035, driven by increasing awareness and advancements in treatment options. **New opportunities:** - Development of personalized gluten-free meal plans for patients - Expansion of telehealth services for remote patient monitoring - Investment in innovative diagnostic tools for early detection By 2035, the market is expected to achieve substantial growth and enhanced treatment accessibility. ## Segment Insights ### By Treatment Type: Gluten Free Diet (Largest) vs. Medical Therapies (Fastest-Growing) In the South Korea celiac disease-treatment market, the distribution of market share among the treatment types reveals that the Gluten Free Diet segment commands the largest share. This is primarily due to its fundamental role in managing the disease, with a significant number of patients adhering to this dietary restriction as their primary method of treatment. Vitamin and Minerals Supplements also contribute to the landscape, but their role is more supportive, providing essential nutrients that patients may miss in their gluten-free diet, while Medical Therapies are emerging with increasing relevance as research progresses. Growth trends in this segment indicate a shift towards more innovative treatment options, particularly in Medical Therapies, which are seen as the fastest-growing area due to advancements in pharmaceutical research. The rising awareness of celiac disease among healthcare professionals and patients is driving this sector's expansion, along with technological enhancements in treatment methodologies. The market sees a dynamic interaction between traditional dietary management and the rising acceptance of medical therapies, with each segment influencing the other. Gluten Free Diet (Dominant) vs. Medical Therapies (Emerging) The Gluten Free Diet segment remains dominant in the South Korea celiac disease-treatment market, representing a cornerstone of treatment strategies for patients. This diet not only serves as a critical method for symptom management but also promotes overall health among individuals with celiac disease. The widespread acknowledgment of its importance makes it the go-to approach for many patients. On the other hand, Medical Therapies are considered an emerging segment, gaining traction as new treatments are developed and tested. These therapies offer a promising alternative or complement to dietary management, leveraging advancements in science and technology to provide patients with options that may enhance their quality of life. Together, these segments reflect a comprehensive approach to managing celiac disease. ### By End User: Hospitals and Clinics (Largest) vs. Research Centers (Fastest-Growing) In the South Korea celiac disease-treatment market, Hospitals and Clinics hold a significant share, serving as the primary access point for patients seeking treatment. This segment benefits from established patient-doctor relationships and the trust associated with well-known healthcare institutions. Research Centers, while smaller in market share, are rapidly gaining traction, driven by advancements in research and increased funding for celiac disease studies. Their role in developing innovative therapies is becoming increasingly vital. The growth trends in this segment are notable, with Hospitals and Clinics expected to maintain their dominance due to the increasing prevalence of celiac disease and the expanding healthcare infrastructure. On the other hand, Research Centers are emerging as the fastest-growing segment, fueled by the rising interest in specialized research initiatives and collaborations with pharmaceutical companies. The growing awareness of gluten-related disorders is driving investment in research, making this segment a key player in the future of celiac disease treatment. Hospitals and Clinics (Dominant) vs. Research Centers (Emerging) Hospitals and Clinics are the dominant force in the South Korea celiac disease-treatment market, providing comprehensive care that ranges from diagnosis to ongoing management of the condition. Their established presence allows them to cater to a large patient base, often integrating interdisciplinary teams to enhance treatment effectiveness. Conversely, Research Centers are emerging as crucial players, focusing on the innovation of treatment protocols and alternative therapies. They benefit from collaborations with healthcare institutions and contribute significantly to understanding and managing celiac disease. With funding and research efforts increasing, Research Centers are expected to lead the way in new treatment discoveries, potentially reshaping the therapeutic landscape. ## Competitive Benchmarking The celiac disease-treatment market in South Korea is characterized by a dynamic competitive landscape, driven by increasing awareness of the condition and a growing demand for effective treatment options. Key players such as AbbVie Inc (US), Gluten Free Holdings Inc (US), and Aimmune Therapeutics Inc (US) are actively shaping the market through innovative product offerings and strategic partnerships. AbbVie Inc (US) has positioned itself as a leader in the market by focusing on research and development, particularly in the area of novel therapies that target the underlying mechanisms of celiac disease. Meanwhile, Gluten Free Holdings Inc (US) emphasizes the importance of gluten-free product development, catering to the dietary needs of patients, which appears to resonate well with the consumer base. Aimmune Therapeutics Inc (US) is also noteworthy for its commitment to advancing immunotherapy solutions, which could potentially transform treatment paradigms in the near future.The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing processes. The market structure is moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. This competitive environment fosters innovation and encourages smaller firms to collaborate with larger entities, thereby enhancing the overall market dynamics. In October AbbVie Inc (US) announced a strategic partnership with a leading South Korean biotech firm to co-develop a new therapeutic agent aimed at reducing the autoimmune response in celiac disease patients. This collaboration is expected to leverage local expertise and accelerate the development timeline, indicating AbbVie’s commitment to expanding its footprint in the region. Such partnerships may enhance the company’s competitive edge by facilitating access to novel technologies and local Market Research Future. In September Aimmune Therapeutics Inc (US) launched a clinical trial for its innovative immunotherapy treatment in South Korea, which aims to desensitize patients to gluten. This trial represents a significant step forward in the company’s strategy to establish a foothold in the Asian market, potentially leading to a breakthrough in treatment options for celiac disease. The implications of successful trial outcomes could be profound, not only for Aimmune but also for the broader treatment landscape. In August Gluten Free Holdings Inc (US) expanded its product line to include a new range of gluten-free snacks specifically designed for children with celiac disease. This move appears to be a strategic response to the increasing demand for specialized dietary products, reflecting a growing trend towards personalized nutrition. By targeting a younger demographic, the company may enhance brand loyalty and capture a larger market share. As of November the competitive trends in the celiac disease-treatment market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. The competitive differentiation is likely to evolve from traditional price-based strategies to a focus on technological advancements, innovative therapies, and reliable supply chains. This shift suggests that companies that prioritize research and development, alongside strategic partnerships, will be better positioned to thrive in the evolving landscape. ## Recent News & Developments In recent months, the South Korea Celiac Disease Treatment Market has seen significant developments, particularly with a focus on innovative therapeutics and enhanced patient support services. There has been increased collaboration among major companies like Yuhan Corporation, JW Pharmaceutical, and Hanmi Pharmaceutical to develop advanced treatments and diagnostic tools for celiac disease. In September 2023, Yuhan Corporation announced successful outcomes from its clinical trials for a promising therapeutic candidate aimed at celiac disease, strengthening its market position.  Furthermore, in July 2023, JW Pharmaceutical and Boryung Pharmaceutical expanded their Research and Development collaborations to address unmet needs in celiac disease treatment.The market has also witnessed a growing public awareness campaign led by DongA ST, aiming to educate patients about gluten-free diets and ongoing treatment options. The Celiac Disease Treatment Market in South Korea is projected to experience notable growth, driven by the increasing incidence of the disease and a rise in healthcare spending. In addition, the government is fostering initiatives to promote policy adjustments benefiting those with celiac disease, enhancing the overall support infrastructure in the country. ## Report Scope | MARKET SIZE 2024 | 7.63 (USD Million) | | --- | --- | | MARKET SIZE 2025 | 8.52 (USD Million) | | MARKET SIZE 2035 | 25.58 (USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.62% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | AbbVie Inc (US), Gluten Free Holdings Inc (US), Alba Therapeutics Corporation (US), TheraBreath (US), Aimmune Therapeutics Inc (US), Celiac Disease Foundation (US), Biomedal S.L. (ES), Nestle S.A. (CH) | | Segments Covered | Treatment Type, End User | | Key Market Opportunities | Emerging gluten-free product innovations cater to increasing consumer demand in the celiac disease-treatment market. | | Key Market Dynamics | Rising demand for gluten-free products drives innovation in celiac disease treatment options within South Korea. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What was the market valuation for the celiac disease-treatment market in 2024?** A: The market valuation for the celiac disease-treatment market was $7.63 Million in 2024. **Q: What is the projected market valuation for 2035?** A: The projected market valuation for 2035 is $25.58 Million. **Q: What is the expected CAGR for the celiac disease-treatment market from 2025 to 2035?** A: The expected CAGR for the celiac disease-treatment market during the forecast period 2025 - 2035 is 11.62%. **Q: Which treatment types are included in the celiac disease-treatment market segments?** A: The treatment types include Gluten Free Diet, Vitamin and Minerals Supplements, and Medical Therapies. **Q: What were the valuations for the Gluten Free Diet segment in 2024?** A: The Gluten Free Diet segment had valuations ranging from $3.5 Million to $12.1 Million. **Q: How do hospitals and clinics contribute to the market?** A: Hospitals and Clinics contributed $3.81 Million to $13.16 Million in the end-user segment. **Q: Who are the key players in the celiac disease-treatment market?** A: Key players include AbbVie Inc, Gluten Free Holdings Inc, and Nestle S.A. **Q: What is the valuation range for Vitamin and Minerals Supplements in 2024?** A: The valuation range for Vitamin and Minerals Supplements was $2.5 Million to $8.5 Million. **Q: What role do research centers play in the market?** A: Research Centers accounted for valuations between $2.29 Million and $7.83 Million in the end-user segment. **Q: What is the projected growth trend for medical therapies in the market?** A: Medical Therapies are projected to grow from $1.63 Million to $5.98 Million during the forecast period. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-celiac-disease-treatment-market-51355*